| 國立成功大學 |
2023 |
Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
|
Chen, P.-C.;Lee, K.-H.;Lee, W.-C.;Yeh, T.-C.;Kuo, Y.-C.;Chiang, B.-J.;Liao, C.-H.;Meng, E.;Kao, Y.-L.;Lee, Y.-C.;Kuo, H.-C. |
| 國立成功大學 |
2023 |
Clinical guidelines of patient-centered bladder management of neurogenic lower urinary tract dysfunction due to chronic spinal cord injury - Part 2: Conservative and minimally invasive treatment
|
Kao, Y.-L.;Chen, J.-T.;Chen, S.-L.;Shao, I.-H.;Wang, C.-C.;Chiang, I.-N.;Hsu, Y.-C.;Lee, K.-H.;Lee, W.-C.;Yeh, T.-C.;Kuo, Y.-C.;Chiang, B.-J.;Liao, C.-H.;Chen, P.-C.;Meng, E.;Lee, Y.-C.;Kuo, H.-C. |
| 國立成功大學 |
2023 |
Psychological Toll of the COVID-19 Pandemic: An In-Depth Exploration of Anxiety, Depression, and Insomnia and the Influence of Quarantine Measures on Daily Life
|
Aljaberi, M.A.;Al-Sharafi, M.A.;Uzir, M.U.H.;Sabah, A.;Ali, Ali A.M.;Lee, K.-H.;Alsalahi, Alsalahi A.;Noman, S.;Lin, C.-Y. |
| 國立成功大學 |
2023 |
Validity and Reliability of a Questionnaire on the Knowledge, Attitudes, Perceptions and Practices toward Food Poisoning among Malaysian Secondary School Students: A Pilot Study
|
Ramu, P.;Osman, M.;Abdul, Mutalib N.A.;Aljaberi, M.A.;Lee, K.-H.;Lin, C.-Y.;Hamat, R.A. |
| 國立成功大學 |
2023 |
Psychometric Properties of the Perceived Collective Family Efficacy Scale in Algeria
|
Sabah, A.;Aljaberi, M.A.;Lee, K.-H.;Lin, C.-Y. |
| 國立成功大學 |
2023 |
Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer
|
Lin, C.-H.;Lin, W.-D.;Huang, Y.-C.;Chen, Y.-C.;Loh, Z.-J.;Ger, L.-P.;Lin, F.-C.;Li, H.-Y.;Cheng, H.-C.;Lee, K.-H.;Hsiao, M.;Lu, P.-J. |
| 國立成功大學 |
2023 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, L.V.;Yang, J.C.-H.;Yamamoto, N.;O'Byrne, K.;Hirsh, V.;Mok, T.;Geater, S.L.;Orlov, S.;Tsai, C.-M.;Boyer, M.;Su, W.-C.;Bennouna, J.;Kato, T.;Gorbunova, V.;Lee, K.H.;Shah, R.;Massey, D.;Zazulina, V.;Shahidi, M.;Schuler, M. |
| 國立成功大學 |
2023 |
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
|
Tsuboi, M.;Herbst, R.S.;John, T.;Kato, T.;Majem, Majem M.;Groh�, C.;Wang, J.;Goldman, J.W.;Lu, S.;Su, W.-C.;De, Marinis F.;Shepherd, F.A.;Lee, K.H.;Le, N.T.;Dechaphunkul, A.;Kowalski, D.;Poole, L.;Bolanos, A.;Rukazenkov, Y.;Wu, Y.-L. |
| 臺大學術典藏 |
2022-09-15T01:08:56Z |
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors
|
Desai J.; Deva S.; Lee J.S.; Chia-Chi Lin; Yen C.-J.; Chao Y.; Keam B.; Jameson M.; Hou M.-M.; Kang Y.-K.; Markman B.; Lu C.-H.; Rau K.-M.; Lee K.-H.; Horvath L.; Friedlander M.; Hill A.; Sandhu S.; Barlow P.; Wu C.-Y.; Zhang Y.; Liang L.; Wu J.; Paton V.; Millward M. |
| 臺大學術典藏 |
2022-09-15T01:08:55Z |
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
|
Paz-Ares L.; Kim T.M.; Vicente D.; Felip E.; Lee D.H.; Lee K.H.; Chia-Chi Lin; Flor M.J.; Di Nicola M.; Alvarez R.M.; Dussault I.; Helwig C.; Ojalvo L.S.; Gulley J.L.; Cho B.C. |
| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
|
Park K.; Tan D.S.W.; Su W.-C.; Cho B.C.; Kim S.-W.; Lee K.H.; Wang C.-C.; Seto T.; Huang D.C.-L.; Jung H.H.; Hsu M.-C.; Bogenrieder T.; Chia-Chi Lin |
| 臺大學術典藏 |
2022-08-19T06:48:44Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; Hsu C.-H.; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.; Chao Y.; Chen J.-S.; Bang Y.-J.; Bendell J.; Lee K.-H.; Wang Y.; Abdullah H.; Liu B.; Spahn J.; Hack S.P.; Verret W.; CHIH-HUNG HSU; Lee M.S. |
| 臺大學術典藏 |
2022-08-19T00:20:33Z |
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
|
Tebbutt N.; Strickler J.; Stein S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Dev A.; Davis S.L.; Chung H.C.; Chen J.-S.; Chao Y.; Bendell J.; Bang Y.-J.; Lee K.-H.; He A.R.; Wang Y.; Liu B.; Abdullah H.; Hack S.P.; Spahn J.; Lee M.S.; Ryoo B.-Y.; Hsu C.-H.; Numata K.; Stein S.; Verret W. |
| 臺大學術典藏 |
2022-08-10T02:37:39Z |
Amivantamab in egfr exon 20 insertion- mutated non-small-cell lung cancer progressing on platinum chemotherapy: Initial results from the chrysalis phase i study
|
Park K.; Haura E.B.; Leighl N.B.; Mitchell P.; Shu C.A.; Girard N.; Viteri S.; Han J.-Y.; Kim S.-W.; Lee C.K.; Sabari J.K.; Spira A.I.; Yang T.-Y.; Kim D.-W.; Lee K.H.; Sanborn R.E.; Trigo J.; Goto K.; Lee J.-S.; CHIH-HSIN YANG; Govindan R.; Bauml J.M.; Garrido P.; Krebs M.G.; Reckamp K.L.; Xie J.; Curtin J.C.; Haddish-Berhane N.; Roshak A.; Millington D.; Lorenzini P.; Thayu M.; Knoblauch R.E.; Cho B.C. |
| 臺大學術典藏 |
2022-08-10T02:37:38Z |
Brigatinib Versus Crizotinib in ALK Inhibitor�VNaive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
|
Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garcia Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.I.; Gettinger S.N.; Tiseo M.; Lin H.M.; Liu Y.; Vranceanu F.; Niu H.; Zhang P.; Popat S. |
| 臺大學術典藏 |
2022-08-09T03:50:57Z |
Electronic and atomic structures of Si-C-N thin film by X-ray-absorption spectroscopy
|
Pong W.F.; Chang Y.K.; Hsieh H.H.; Tsai M.-H.; Lee K.H.; Dann T.E.; Chien F.Z.; Tseng P.K.; Tsang K.L.; Su W.K.; Chen L.C.; Wei S.L.; Chen K.H.; Bhusari D.M.; Chen Y.F.; Pong W.F.; Chen L.C.; Wei S.L.; Chen Y.F.; LI-CHYONG CHEN |
| 臺大學術典藏 |
2022-07-12T01:43:01Z |
Sexual and bladder dysfunction in male ketamine abusers: A large-scale questionnaire study
|
Yang S.S.-D.; Jang M.-Y.; Lee K.-H.; Hsu W.-T.; Chen Y.-C.; Chen W.-S.; SHANG-JEN CHANG |
| 臺大學術典藏 |
2022-05-13T02:40:47Z |
Norepinephrine administration is associated with higher mortality in dialysis requiring acute kidney injury patients with septic shock
|
Chen Y.-Y.; Wu V.-C.; Huang W.-C.; Yeh Y.-C.; Wu M.-S.; Huang C.-C.; Wu K.-D.; Fang J.-T.; Wu C.-J.; Wu V.-C.; Lai T.-S.; Lin Y.-F.; Tsai I.-J.; Lai C.-F.; TAO-MIN HUANG; Chu T.-S.; Chen Y.-M.; Chang Y.-H.; Yeh Y.-C.; Lai C.-H.; Tseng L.-J.; Wu K.-D.; Wang J.-J.; Chen C.-Y.; Shiao C.-C.; Wang W.-J.; Lin J.-H.; Wu C.-H.; Wu C.-J.; Lu K.-C.; Kan W.-C.; Huang C.-C.; Chou C.-Y.; Yang Y.-F.; Tsai J.-P.; Hu F.-C.; Lee C.-T.; Chen J.-B.; Lee C.-H.; Lee W.-C.; Li L.-C.; Chen T.-C.; Lin H.Y.-H.; Chen Y.-C.; Lee C.-C.; Sun C.-Y.; Pan H.-C.; Chang M.-Y.; Jenq C.-C.; Lin C.-Y.; Chang C.-H.; Tsai T.-Y.; Chen C.-M.; Lin E.-T.; Wu C.-J.; Lin C.-J.; Wu P.-C.; Kuo F.-C.; Weng C.-J.; Chen L.-K.; Lin S.-L.; Yang W.-S.; Hsu W.-D.; Leu J.-G.; Chang J.-T.; Liou H.-H.; Hsu K.-H.; Wu M.-J.; Huang C.-T.; You Z.-H.; Chang C.-F.; Chen T.-W.; Chen H.-H.; Chang F.-C.; Lin Y.-C.; Wu M.-S.; Kao C.-C.; Hung S.-C.; Kuo K.-L.; Wu C.-H.; Tarng D.-C.; Chen J.-Y.; Yang C.-Y.; Lee K.-H.; Ko S.-W.; The NSARF, CAKS Group |
| 臺大學術典藏 |
2022-05-11T08:25:41Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN; Lu Y.-S.; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. |
| 臺大學術典藏 |
2022-04-28T12:31:42Z |
Nationwide epidemiology and prognosis of dialysis-requiring acute kidney injury (NEP-AKI-D) study: Design and methods
|
Shiao C.-C.; Wu P.-C.; Wu V.-C.; Lin J.-H.; Pan H.-C.; Yang Y.-F.; Lai T.-S.; Huang T.-M.; Wu C.-H.; Yang W.-S.; Wu C.-J.; Kao C.-C.; Sun C.-Y.; Huang C.-T.; Lee K.-H.; Lin C.-Y.; Chen T.-C.; Hu F.-C.; Liou H.-H.; Lu K.-C.; Chien K.-L.; Wang J.-J.; Kan W.-C.; Kuo F.-C.; Lin H.Y.-H.; Chen C.-M.; You Z.-H.; Tsai J.-P.; Weng C.-J.; Chen H.-Y.; Chang C.-F.; Hsu W.-D.; Wu M.-S.; Huang C.-C.; Wu K.-D.; on behalf of the Taiwan Consortium for Acute Kidney Injury Renal Diseases (CAKs); KUO-LIONG CHIEN |
| 臺大學術典藏 |
2022-04-25T03:57:24Z |
Connecting MHC-I-binding motifs with HLA alleles via deep learning
|
Lee K.-H;Chang Y.-C;Chen T.-F;Juan H.-F;Tsai H.-K;Chen C.-Y.; Lee K.-H; Chang Y.-C; Chen T.-F; Juan H.-F; Tsai H.-K; Chen C.-Y.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2022-03-31T09:03:41Z |
Transgenerational effects of di(2-ethylhexyl) phthalate on anogenital distance, sperm functions and dna methylation in rat offspring
|
Hsu P.-C.; Jhong J.-Y.; Huang L.-P.; Lee K.-H.; Chen H.-P.; YUE-LIANG GUO |
| 臺大學術典藏 |
2022-03-29T07:00:02Z |
Intra-Colonial Functional Differentiation-Related Modulation of the Cellular Membrane in a Pocilloporid Coral Seriatopora caliendrum
|
Tang C.-H.; Ku P.-C.; CHING-YU LIN; Chen T.-H.; Lee K.-H.; Lee S.-H.; Wang W.-H. |
| 臺大學術典藏 |
2022-03-14T12:48:22Z |
QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells
|
Chen M.-C.; Pan S.-L.; Shi Q.; Xiao Z.; Lee K.-H.; TSAI-KUN LI; Teng C.-M. |
| 臺大學術典藏 |
2022-02-21T02:04:35Z |
Pembrolizumab as second-line therapy for advanced hepatocellular carcinoma: A subgroup analysis of asian patients in the phase 3 KEYNOTE-240 trial
|
Kudo M.; Lim H.Y.; ANN-LII CHENG; Chao Y.; Yau T.; Ogasawara S.; Kurosaki M.; Morimoto N.; Ohkawa K.; Yamashita T.; Lee K.-H.; Chen E.; Siegel A.B.; Ryoo B.-Y. |
